Insulin Resistance and Chronic Kidney Disease in Patients with Type 1 Diabetes Mellitus

Background and Aims. Diabetes mellitus (DM) is a chronic disease which can evolve towards devastating micro- and macrovascular complications. DM is the most frequent cause of chronic kidney disease (CKD). Insulin resistance plays an important role in the natural history of type 1 diabetes. The purpo...

Full description

Saved in:
Bibliographic Details
Main Authors: Mihaela Vladu, Diana Clenciu, Ion Cristian Efrem, Mircea-Cătalin Forțofoiu, Anca Amzolini, Simona Tudorică Micu, Maria Moţa, Maria Forțofoiu
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Journal of Nutrition and Metabolism
Online Access:http://dx.doi.org/10.1155/2017/6425359
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548373340618752
author Mihaela Vladu
Diana Clenciu
Ion Cristian Efrem
Mircea-Cătalin Forțofoiu
Anca Amzolini
Simona Tudorică Micu
Maria Moţa
Maria Forțofoiu
author_facet Mihaela Vladu
Diana Clenciu
Ion Cristian Efrem
Mircea-Cătalin Forțofoiu
Anca Amzolini
Simona Tudorică Micu
Maria Moţa
Maria Forțofoiu
author_sort Mihaela Vladu
collection DOAJ
description Background and Aims. Diabetes mellitus (DM) is a chronic disease which can evolve towards devastating micro- and macrovascular complications. DM is the most frequent cause of chronic kidney disease (CKD). Insulin resistance plays an important role in the natural history of type 1 diabetes. The purpose of the study was to determine the prevalence of CKD in T1DM and the correlation with insulin resistance (IR) in patients with CKD. Materials and Methods. The study was conducted over a period of three years (2010–2013) and included patients with DM registered in the Clinical Centre of Diabetes, Nutrition and Metabolic Diseases of Dolj county. The study design was an epidemiological, transversal, noninterventional type. Finally, the study group included 200 subjects with type 1 DM. Insulin resistance (IR) was estimated by eGDR. The subjects with eGDR ≤ 7.5 mg/kg/min were considered with insulin resistance. Results. CKD was found in 44% of the patients. Analyzing statistically the presence of CKD, we found highly significant differences between patients with CKD and those without CKD regarding age and sex of the patients, the duration of diabetes, glycosylated hemoglobin (HbA1c), the estimated glucose disposal rate (eGDR), and the presence of hypertension, dyslipidemia, and hyperuricaemia. In patients with CKD, age and diabetes duration are significantly higher than in those who do not have this complication. CKD is more frequent in males than in females (50.9% men versus 34.5% women, p=0.022). From the elements of metabolic syndrome, high blood pressure, hyperuricemia, and dyslipidemia are significantly increased in diabetic patients with CKD. eGDR value (expressed as mg·kg−1·min−1) is lower in patients with CKD than in those without CKD (15.92 versus 6.42, p<0.001) indicating the fact that patients with CKD show higher insulin resistance than those without CKD. Conclusions. This study has shown that insulin resistance is associated with an increased risk of CKD, but, due to the cross-sectional design, the causal relationship cannot be assessed. However, the existence of this causality and the treatment benefit of insulin resistance in type 1 diabetes are issues for further discussion.
format Article
id doaj-art-f8a53773f56d44b090e6962b98b03be7
institution Kabale University
issn 2090-0724
2090-0732
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Journal of Nutrition and Metabolism
spelling doaj-art-f8a53773f56d44b090e6962b98b03be72025-02-03T06:14:17ZengWileyJournal of Nutrition and Metabolism2090-07242090-07322017-01-01201710.1155/2017/64253596425359Insulin Resistance and Chronic Kidney Disease in Patients with Type 1 Diabetes MellitusMihaela Vladu0Diana Clenciu1Ion Cristian Efrem2Mircea-Cătalin Forțofoiu3Anca Amzolini4Simona Tudorică Micu5Maria Moţa6Maria Forțofoiu7University of Medicine and Pharmacy of Craiova, Craiova, RomaniaClinical Municipal Hospital “Philanthropy” of Craiova, Craiova, RomaniaUniversity of Medicine and Pharmacy of Craiova, Craiova, RomaniaUniversity of Medicine and Pharmacy of Craiova, Craiova, RomaniaUniversity of Medicine and Pharmacy of Craiova, Craiova, RomaniaUniversity of Medicine and Pharmacy of Craiova, Craiova, RomaniaUniversity of Medicine and Pharmacy of Craiova, Craiova, RomaniaUniversity of Medicine and Pharmacy of Craiova, Craiova, RomaniaBackground and Aims. Diabetes mellitus (DM) is a chronic disease which can evolve towards devastating micro- and macrovascular complications. DM is the most frequent cause of chronic kidney disease (CKD). Insulin resistance plays an important role in the natural history of type 1 diabetes. The purpose of the study was to determine the prevalence of CKD in T1DM and the correlation with insulin resistance (IR) in patients with CKD. Materials and Methods. The study was conducted over a period of three years (2010–2013) and included patients with DM registered in the Clinical Centre of Diabetes, Nutrition and Metabolic Diseases of Dolj county. The study design was an epidemiological, transversal, noninterventional type. Finally, the study group included 200 subjects with type 1 DM. Insulin resistance (IR) was estimated by eGDR. The subjects with eGDR ≤ 7.5 mg/kg/min were considered with insulin resistance. Results. CKD was found in 44% of the patients. Analyzing statistically the presence of CKD, we found highly significant differences between patients with CKD and those without CKD regarding age and sex of the patients, the duration of diabetes, glycosylated hemoglobin (HbA1c), the estimated glucose disposal rate (eGDR), and the presence of hypertension, dyslipidemia, and hyperuricaemia. In patients with CKD, age and diabetes duration are significantly higher than in those who do not have this complication. CKD is more frequent in males than in females (50.9% men versus 34.5% women, p=0.022). From the elements of metabolic syndrome, high blood pressure, hyperuricemia, and dyslipidemia are significantly increased in diabetic patients with CKD. eGDR value (expressed as mg·kg−1·min−1) is lower in patients with CKD than in those without CKD (15.92 versus 6.42, p<0.001) indicating the fact that patients with CKD show higher insulin resistance than those without CKD. Conclusions. This study has shown that insulin resistance is associated with an increased risk of CKD, but, due to the cross-sectional design, the causal relationship cannot be assessed. However, the existence of this causality and the treatment benefit of insulin resistance in type 1 diabetes are issues for further discussion.http://dx.doi.org/10.1155/2017/6425359
spellingShingle Mihaela Vladu
Diana Clenciu
Ion Cristian Efrem
Mircea-Cătalin Forțofoiu
Anca Amzolini
Simona Tudorică Micu
Maria Moţa
Maria Forțofoiu
Insulin Resistance and Chronic Kidney Disease in Patients with Type 1 Diabetes Mellitus
Journal of Nutrition and Metabolism
title Insulin Resistance and Chronic Kidney Disease in Patients with Type 1 Diabetes Mellitus
title_full Insulin Resistance and Chronic Kidney Disease in Patients with Type 1 Diabetes Mellitus
title_fullStr Insulin Resistance and Chronic Kidney Disease in Patients with Type 1 Diabetes Mellitus
title_full_unstemmed Insulin Resistance and Chronic Kidney Disease in Patients with Type 1 Diabetes Mellitus
title_short Insulin Resistance and Chronic Kidney Disease in Patients with Type 1 Diabetes Mellitus
title_sort insulin resistance and chronic kidney disease in patients with type 1 diabetes mellitus
url http://dx.doi.org/10.1155/2017/6425359
work_keys_str_mv AT mihaelavladu insulinresistanceandchronickidneydiseaseinpatientswithtype1diabetesmellitus
AT dianaclenciu insulinresistanceandchronickidneydiseaseinpatientswithtype1diabetesmellitus
AT ioncristianefrem insulinresistanceandchronickidneydiseaseinpatientswithtype1diabetesmellitus
AT mirceacatalinfortofoiu insulinresistanceandchronickidneydiseaseinpatientswithtype1diabetesmellitus
AT ancaamzolini insulinresistanceandchronickidneydiseaseinpatientswithtype1diabetesmellitus
AT simonatudoricamicu insulinresistanceandchronickidneydiseaseinpatientswithtype1diabetesmellitus
AT mariamota insulinresistanceandchronickidneydiseaseinpatientswithtype1diabetesmellitus
AT mariafortofoiu insulinresistanceandchronickidneydiseaseinpatientswithtype1diabetesmellitus